Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 26 | $14,388,053 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Dec 2024 | Sale | 58,184 | 5.0013 | 290,996 | D |
06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 05 Dec 2024 | Sale | 640,048 | 5.0061 | 3,204,144 | D |
06 Dec 2024 17:50 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 06 Dec 2024 | Sale | 183,728 | 5.0091 | 920,312 | D |
02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 27 Nov 2024 | Sale | 12,936 | 5 | 64,680 | D |
02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 29 Nov 2024 | Sale | 98,704 | 5.0063 | 494,142 | D |
02 Dec 2024 19:20 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Dec 2024 | Sale | 1,600 | 5 | 8,000 | D |
26 Nov 2024 18:36 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 25 Nov 2024 | Sale | 1,600 | 5 | 8,000 | D |
26 Nov 2024 18:36 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 26 Nov 2024 | Sale | 800 | 5 | 4,000 | D |
13 Nov 2024 16:57 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 11 Nov 2024 | Sale | 2,400 | 5 | 12,000 | D |
05 Nov 2024 17:40 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Nov 2024 | Sale | 48,888 | 4.3761 | 213,939 | D |
05 Nov 2024 17:40 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Nov 2024 | Sale | 80,784 | 4.3876 | 354,448 | D |
25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 24 Oct 2024 | Sale | 141,360 | 4.3772 | 618,761 | D |
25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 25 Oct 2024 | Sale | 3,200 | 4.375 | 14,000 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 18 Oct 2024 | Sale | 249,728 | 4.3807 | 1,093,983 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 21 Oct 2024 | Sale | 116,696 | 4.3796 | 511,082 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 22 Oct 2024 | Sale | 159,344 | 4.3849 | 698,708 | D |
13 Sep 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 11 Sep 2024 | Sale | 600,000 | 3.7568 | 2,254,080 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 3,736 | 3.25 | 12,142 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 394,664 | 3.2012 | 1,263,398 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 12 Aug 2024 | Sale | 1,600 | 3.13 | 5,008 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
03 May 2023 19:48 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 May 2023 | Sale | 455,528 | 2.5759 | 1,173,395 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)